Beam Therapeutics

Halal Rating :
See Details
Last Price $22.39 Last updated:
Market Cap $1.86b
7D Change -5.13%
1 Year Change -53.25%

Company Overview

  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing
Exchange NASDAQ
Next Earnings Date Nov. 6, 2023

Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. The company is headquartered in Cambridge, Massachusetts.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
June 30, 2023 $20.12m $122.26m - $11.95m 0.00% 9.78%
March 31, 2023 $24.21m $123.14m - $9.96m 0.00% 8.09%
Dec. 31, 2022 $20.36m $109.02m - $7.61m 0.00% 6.98%

Company Impact

Help us evaluate Beam Therapeutics's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating


Name Description Password Date Published
Are we buying Beam Therapeutics (BEAM)? Privileged Article subscribe for access 05/05/2022

Recent News & Updates